Cadian Capital Management, LP Maxcyte, Inc. Put Options Transaction History
Cadian Capital Management, LP
- $2.34 Billion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding MXCT
# of Institutions
115Shares Held
69.5MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY8.14MShares$18.2 Million0.0% of portfolio
-
Morgan Stanley New York, NY7MShares$15.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.57MShares$12.5 Million0.0% of portfolio
-
Vitruvian Partners LLP5.04MShares$11.3 Million13.13% of portfolio
-
Mirabella Financial Services LLP London, X03.7MShares$8.29 Million0.43% of portfolio
About MAXCYTE, INC.
- Ticker MXCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 101,724,000
- Market Cap $228M
- Description
- MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...